Martínez-Sánchez FD, Gutierrez-Rosas LE, Barranco-Hernandez LH, Gonzalez-Alvarez G, Bastida-Castro LA, Rocha-Haro A, Barrientos-Cabrera G, Martínez-Cabrera CF, Balderas-Juarez J, Salinas-Ramirez MA, Hernandez-Castillo JL. Hyponatremia: Evolving diagnostics and emerging therapeutics in clinical practice. World J Nephrol 2026; 15(1): 115252 [DOI: 10.5527/wjn.v15.i1.115252]
Corresponding Author of This Article
Froylan David Martínez-Sánchez, MD, MSc, Professor, Department of Internal Medicine, Hospital General Dr. Manuel Gea Gonzalez, Calz. de Tlalpan 4800, Belisario Domínguez Secc 16, Tlalpan 14080, Ciudad de México, Mexico. froylan.martinez@comunidad.unam.mx
Research Domain of This Article
Urology & Nephrology
Article-Type of This Article
Minireviews
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Nephrol. Mar 25, 2026; 15(1): 115252 Published online Mar 25, 2026. doi: 10.5527/wjn.v15.i1.115252
Hyponatremia: Evolving diagnostics and emerging therapeutics in clinical practice
Froylan David Martínez-Sánchez, Luis Enrique Gutierrez-Rosas, Luis Hernan Barranco-Hernandez, Gibran Gonzalez-Alvarez, Luis A Bastida-Castro, Andrea Rocha-Haro, German Barrientos-Cabrera, Carlos Fernando Martínez-Cabrera, Joana Balderas-Juarez, Mauricio A Salinas-Ramirez, Jose L Hernandez-Castillo
Froylan David Martínez-Sánchez, Luis Hernan Barranco-Hernandez, Gibran Gonzalez-Alvarez, Luis A Bastida-Castro, German Barrientos-Cabrera, Department of Internal Medicine, Hospital General Dr. Manuel Gea Gonzalez, Tlalpan 14080, Ciudad de México, Mexico
Froylan David Martínez-Sánchez, Carlos Fernando Martínez-Cabrera, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Coyoacán 04360, Ciudad de México, Mexico
Froylan David Martínez-Sánchez, Luis Enrique Gutierrez-Rosas, Carlos Fernando Martínez-Cabrera, Centro de Investigación y Gastroenterología, Benito Juárez 03330, Ciudad de México, Mexico
Andrea Rocha-Haro, Department of Internal Medicine, Jackson Memorial Hospital, Miami, FL 33136, United States
Joana Balderas-Juarez, Mauricio A Salinas-Ramirez, Jose L Hernandez-Castillo, Department of Nephrology, Hospital General Dr. Manuel Gea Gonzalez, Tlalpan 14080, Ciudad de México, Mexico
Author contributions: Martínez-Sánchez FD, Gutierrez-Rosas LE, and Barranco-Hernandez LH contributed equally to the conception, design, and drafting of the manuscript; Martínez-Sánchez FD, Gutierrez-Rosas LE, and Gonzalez-Alvarez G were responsible for the design and creation of the figures; Gonzalez-Alvarez G, Bastida-Castro LA, Rocha-Haro A, Barrientos-Cabrera G, Martínez-Cabrera CF, Balderas-Juarez J, Salinas-Ramírez MA, and Hernández-Castillo JL contributed to the literature review and critical content revision; Martínez-Sánchez FD and Rocha-Haro A were responsible for English language revision and verification of the final manuscript. Martínez-Sánchez FD critically reviewed the final version and approved it for submission. All authors read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Corresponding author: Froylan David Martínez-Sánchez, MD, MSc, Professor, Department of Internal Medicine, Hospital General Dr. Manuel Gea Gonzalez, Calz. de Tlalpan 4800, Belisario Domínguez Secc 16, Tlalpan 14080, Ciudad de México, Mexico. froylan.martinez@comunidad.unam.mx
Received: October 15, 2025 Revised: November 19, 2025 Accepted: January 16, 2026 Published online: March 25, 2026 Processing time: 152 Days and 21.7 Hours
Abstract
Hyponatremia remains the most common electrolyte disorder in clinical practice, with a wide range of causes ranging from endocrine dysregulation to iatrogenic causes. Recent developments in point-of-care ultrasonography, vasopressin physiology, and osmoregulation have transformed diagnostics by emphasizing accuracy above purely clinical judgment. Although traditional management based on fluid restriction and hypertonic solutions remain the cornerstone of treatment, a careful and cautious monitoring is required to avoid osmotic demyelination and overcorrection. The Furst equation, a validated predictor of response to fluid restriction, should be integrated into routine practice, together with objective tools such as point-of-care ultrasonography, to improve the accuracy of volume assessment and guide more precise therapeutic decisions. Likewise, different therapeutic options have been studied for non-responders to fluid restriction, including urea, desmopressin, and selective vasopressin receptor antagonists (vaptans), showing promising results. Ongoing developments in artificial intelligence and laboratory-based decision support tools are expected to improve personalized management and predictive accuracy, potentially reconciling the disparity between evidence and clinical practice.
Core Tip: Hyponatremia, defined as a low concentration of sodium in the blood, is the most frequent electrolyte disorder in clinical practice. Its causes are diverse and often overlap, from hormonal imbalances to medication effects or underlying heart, liver, and kidney conditions. Effective and safe correction depends on accurately identifying whether the body has too much or too little water, rather than simply restricting fluids. Bedside ultrasound (point-of-care ultrasonography) and simple laboratory tools such as the Furst equation allow clinicians to assess fluid status objectively, predict response to fluid restriction, and guide personalized treatment strategies that reduce complications and improve patient outcomes.